Biomarkers and diagnostic guidelines for sporadic Creutzfeldt–Jakob disease

Dr Geschwind discusses how novel biomarkers and recent guideline updates may improve the diagnosis of sporadic Creutzfeldt–Jakob disease.

Dr. Geschwind has disclosed that he is/was a consultant/advisor for MedConnect Health and MicroVention Terumo.